THE HEALTHCARE EDGE — February 25, 2026
The federal government is simultaneously tightening AI oversight while loosening it—CMS is building algorithmic prior auth systems for 45M+ Medicare beneficiaries with unclear validation standards, while the FDA just appointed an AI-friendly exec to soften device regulation. For practice owners, this means your authorization workflows are about to get algorithmic, your patient data just became a regulatory target, and the healthcare directory finally coming online will either streamline referrals or create new compliance headaches. Meanwhile, Medicare Advantage growth collapsed to 1%, OhioHealth is being crushed by antitrust suits, and hospital systems are fighting to kill charity care obligations—margin pressure is accelerating across the board.
THE AI EDGE
The regulatory guardrails on healthcare AI are coming down just as algorithmic decision-making is moving into the center of patient care. The FDA appointed Rick Abramson (former Harrison.ai CMO) as director of its Digital Health Center of Excellence, signaling a friendlier stance toward AI device oversight—expect faster approvals and lighter hand-holding on validation. Meanwhile, CMS is planning AI-driven Medicare coverage decisions that could influence the entire authorization process for 45M+ beneficiaries, a major shift to algorithmic prior auth with validation standards that remain unclear. Translation: your denials are about to get harder to appeal because the decision-maker won't be a human reviewer.
The infrastructure layer is moving fast too. HHS published its Living Open Data Plan and refreshed HealthData.gov to break down data silos and accelerate research access—your patient data will be flowing into more research pipelines, which means HIPAA compliance becomes table stakes. And CMS will launch a federal provider directory with updated contact and insurance data this year, a decade-long push to fix error-prone directories that cost patients time and drive unnecessary denials.
TODAY'S TOP STORIES
The antitrust hammer is falling on consolidated health systems. The DOJ and Ohio AG sued OhioHealth for anticompetitive contract practices—anti-steering clauses, all-or-nothing deals—that suppress competition and inflate costs. It's the latest nonprofit system facing federal scrutiny, and a signal that nonprofit status is no longer a shield. In Oregon, hospitals are pushing to weaken the 2023 charity care law, citing revenue losses, while patient advocates warn rollback would reinstate medical debt for thousands. For practice owners in consolidated markets: if your largest referral partner is losing on price competition, your reimbursement rates are next.
On the payer side, Medicare Advantage enrollment growth collapsed to 1%—35.5M beneficiaries as of Feb 1, down from historical 7-10% annual growth. Market saturation is real, and shrinking MA margins will ripple directly into provider reimbursement. Expect MA plans to get aggressive on denials and prior auth to protect what's left. A health insurer just settled a $5.1M HIPAA penalty for a breach exposing 9.3M people's PHI, and a nursing home vendor paid $650K for failing to safeguard resident data—if you're using cloud vendors or outsourced billing, these enforcement actions should trigger a security audit.
Washington remains chaotic. NIH Director Jay Bhattacharya will now lead CDC on an acting basis while keeping his NIH role—the third leadership change in six months, signaling deep instability on vaccination and public health strategy. Oregon and 14 other states sued the Trump administration over its vaccine rollback, a legal challenge that could land practices in the middle of conflicting state and federal guidance. At the State of the Union, Trump claimed his most-favored nation drug pricing policy cut US costs from world's highest to lowest—but 50%+ of Americans still say healthcare is unaffordable. And RFK Jr. announced he'll act on a petition to regulate ultra-processed foods, a move that could reshape reimbursement for nutrition-related chronic disease if FDA definitions shift.
DATA POINT
1% — Medicare Advantage enrollment growth dropped to its lowest rate in two decades (35.5M beneficiaries as of Feb 1), down from historical 7-10% annually. Shrinking MA margins will ripple directly into provider reimbursement rates.
Built by the team behind Praxis AI — intelligence for modern healthcare. Read more on our blog.
